AVALO THERAPEUTICS, INC. (AVTX)

SEC filing

AVALO THERAPEUTICS, INC.

AVTX · CIK 1534120

4 · Nov 17, 2025 · Goldman Jonathan sold 11.37K shares at $14.33/share ($162.9K); exercised options for 8,200 shares

Goldman Jonathan sold 11.37K shares at $14.33/share ($162.9K); exercised options for 8,200 shares

PRIMARY DOCUMENT

xslF345X05/primary_doc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).